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Effects of Melanocortin 3 and 4 
Receptor Deficiency on Energy 
Homeostasis in Rats
Panpan You1,*, Handan Hu1,*, Yuting Chen1,*, Yongliang Zhao1, Yiqing Yang1, Tongtong Wang1, 
Roumei Xing1, Yanjiao Shao1, Wen Zhang2, Dali Li1, Huaqing Chen1 & Mingyao Liu1,3
Melanocortin-3 and 4 receptors (MC3R and MC4R) can regulate energy homeostasis, but their 
respective roles especially the functions of MC3R need more exploration. Here Mc3r and Mc4r single and 
double knockout (DKO) rats were generated using CRISPR-Cas9 system. Metabolic phenotypes were 
examined and data were compared systematically. Mc3r KO rats displayed hypophagia and decreased 
body weight, while Mc4r KO and DKO exhibited hyperphagia and increased body weight. All three 
mutants showed increased white adipose tissue mass and adipocyte size. Interestingly, although Mc3r 
KO did not show a significant elevation in lipids as seen in Mc4r KO, DKO displayed even higher lipid 
levels than Mc4r KO. DKO also showed more severe glucose intolerance and hyperglycaemia than Mc4r 
KO. These data demonstrated MC3R deficiency caused a reduction of food intake and body weight, 
whereas at the same time exhibited additive effects on top of MC4R deficiency on lipid and glucose 
metabolism. This is the first phenotypic analysis and systematic comparison of Mc3r KO, Mc4r KO and 
DKO rats on a homogenous genetic background. These mutant rats will be important in defining the 
complicated signalling pathways of MC3R and MC4R. Both Mc4r KO and DKO are good models for 
obesity and diabetes research.
The melanocortin system plays an important physiological role in energy homeostasis1. Melanocortin-3 and 
4 receptors (MC3R and MC4R) are two neural melanocortin receptors that belong to the rhodopsin-like G 
protein-coupled receptor family. MC4R is expressed throughout the central nervous system (CNS)2, and muta-
tions in the MC4R gene are the most common cause of monogenic obesity in human3–6. Many researchers 
reported that MC4R participates in regulating feeding behavior and energy expenditure7,8. In addition, MC4R is 
expressed in peripheral such as adipose tissue9. Recently it was recognized as the second most highly expressed G 
protein-coupled receptor in enteroendocrine L cells, which suggests that peripheral MC4R is important in spe-
cific physiological functions10. MC3R is also expressed in CNS especially in the arcuate nucleus, as well as some 
peripheral tissues such as heart and peritoneal macrophages11–14. Studies in human and rodents have confirmed 
MC3R expression in the kidney, where it participates in modulation of natriuresis13,15. Importantly, MC3R has 
been found to play a subtle role in regulating energy homeostasis12,16. There are also some reports about the influ-
ence of variant Mc3r alleles on human obesity17–19, especially the recent paper about replacing mouse locus with 
human obesity related MC3R double-mutant suggesting an important role of MC3R in human metabolism20.
Mc4r and Mc3r knockout (KO) mouse models have provided some evidence for their respective role in energy 
homeostasis. Mc4r KO mice exhibited obesity, hyperphagia, hyperglycaemia and hyperinsulinemia8,21, while 
Mc3r KO mice displayed almost the same body weight as WT control up to 26 weeks of age, but they did exhibit 
a mild obesity phenotype characterized by increased fat mass, reduced lean mass and reduced body length16. 
Although not much data is available about Mc4r/Mc3r double KO (DKO) mice, they were reported to be signif-
icantly more obese than Mc4r KO mice16. As genetic background can significantly influence the phenotype of 
obesity22,23, a true phenotypic comparison among Mc3r KO, Mc4r KO and DKO in the same congenic background 
would give more valuable information.
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The laboratory rat is a valuable mammalian model organism for many human diseases and has advantages 
over the mouse such as in metabolic and pharmacological studies. The first functional knockout rat (Wistar/
Crl background) for Mc4r (Mc4rK314X) was reported in 2011 as the result of an N-ethyl-N-nitrosourea-induced 
point mutation24, and exhibited increased body weight, food intake and white adipose mass, and altered substrate 
preference25. In 2013 we published the generation of Mc4r KO, and Mc4r/Mc3r DKO rat by CRISPR-Cas9 and 
observed a similar phenotype of the Mc4r KO rat in body weight, food intake, insulin and leptin level as compared 
to the N-ethyl-N-nitrosourea-induced Mc4r KO rat, although these observations were only based on founders 
with biallelic mutants26. Meanwhile, no report on phenotypic analysis of the Mc3r KO rat or Mc3r/Mc4r DKO 
rat was found. In this study, an investigation on Mc3r KO, Mc4r KO, and DKO rats was carried out and data were 
compared systematically regarding their metabolic phenotypes in a single genetic background, in order to pro-
vide an overall understanding of these two receptors in energy metabolism, and to evaluate the possibility of using 
these KO rats as suitable animal models for obesity or type 2 diabetes. Results showed that MC4R deficiency led 
to a dramatic alteration in energy homeostasis including obesity and hyperglycaemia, whereas MC3R deficiency 
showed hypophagia and reduced body weight. However, MC3R deficiency appeared to exert an additive effect on 
MC4R deficiency in several aspects including lipid profile and glucose metabolism which implies that different 
pathways mediated MC3R’s effect on different functions. Data from our extensive phenotypic comparison sug-
gested that Mc4r KO and DKO might be good rat models for obesity or type 2 diabetes (T2D).
Results
Effect of MC3R and MC4R deficiency on growth curve, size and Lee’s index. Heritable total Mc3r 
and Mc4r knockout (KO) rats were generated using CRISPR-Cas9 system in Sprague Dawley (SD) rats26. DNA 
sequences of Mc3r or Mc4r genomic loci in mutant rats were verified as correct. The expression of Mc3r and Mc4r 
in liver, brain and visceral total white adipose tissue (WAT) of mutants reduced significantly as compared with 
WT (Supplementary Fig. S1). This indicates that premature stop codons decreased mutant mRNA stability, as it is 
well established that frameshift or nonsense mutations induce mRNA decay27. All Mc3r, Mc4r single KO and dou-
ble KO rats appeared normal phenotypically except for changed body size. We monitored the body weight of male 
and female Mc3r KO and Mc4r KO rats from 4–18 weeks old, and DKO rats from postnatal day (PND) 45 to 85. It 
was found that Mc3r KO displayed a significantly reduced body weight as compared to WT littermates, beginning 
at PND 58 in males and PND 28 in females (Fig. 1a,b, n = 8, male p = 0.0006, female p < 0.0001, Supplementary 
Fig. S2). Meanwhile, Mc4r KO and DKO showed approximate same degree of increased body weight, with the 
only exception at time points near PND 50 (Fig. 1a,b).
The body length of different groups of rats was measured at 14 weeks of age. As shown in Fig. 1c,d, Mc4r KO 
and DKO rats were significantly longer than WT littermates (n = 4–8, male and female p = 0.02 for Mc4r KO, 
male p = 0.02, female p = 0.04 for DKO). However, the average body length of Mc3r KO rats was significantly 
shorter (Fig. 1c,d, n = 8, male p = 0.002, female p = 0.0008), which was consistent with previous reports on mice. 
As an indicator of obesity, Lee’s index was calculated based on body weight and body length. No change was 
observed in Mc3r KO, while in Mc4r KO and DKO the same significant increase was revealed (Fig. 1e,f, n = 4–8, 
male p = 0.001, female p = 0.006 for Mc4r KO, male p = 0.01, female p = 0.005 for DKO). Thus, MC3R deficiency 
resulted in a shorter, lighter rat, while in Mc4r KO and DKO, increase in body weight was consistent with the 
increase in body length and Lee’s index.
Food and water intake in Mc3r, Mc4r KO and DKO rats. Next we proceeded to monitor food and 
water consumption in different groups. Consistent with their body weight changes, Mc3r KO rats displayed a 
decreased food intake especially in females, as well as a reduction in water intake that did not reach significant 
levels as compared to WT littermates. Conversely, Mc4r KO and DKO had an increased food intake as well as 
water intake as compared to WT rats (Fig. 2). Thus the Mc3r KO rat was hypophagic while Mc4r KO and DKO 
rats were both hyperphagic.
Characterization of serum lipid profile and adipose accumulation. Serum obtained from Mc4r KO 
and DKO rats appeared thick and milky white, obviously abnormal as compared to those of WT and Mc3r KO 
which were clear and yellowish (Fig. 3a). As expected, the lipid profile of Mc4r KO and DKO rats showed signif-
icantly increased total cholesterol (p = 0.01 for Mc4r KO, p < 0.0001 for DKO), triglyceride (p = 0.008 for Mc4r 
KO, p < 0.0001 for DKO) and free fatty acid (p = 0.007 for Mc4r KO, p = 0.0005 for DKO) (Fig. 3b–d, n = 10–16). 
Not much change was found in low-density lipoprotein cholesterol (LDL-c) and high-density lipoprotein choles-
terol (HDL-c), except an increase in LDL-c was manifested in DKO rats (Fig. 3e,f). Interestingly, although Mc3r 
KO did not induce any significant alteration in lipid profile, it did show an additive effect to Mc4r KO on elevation 
of serum lipids (Fig. 3b–d). In addition, all three mutant rats displayed significantly increased WAT weight as 
well as percentage of body weight (Fig. 4a,b, n = 4–8, p ≤ 0.0001; Fig. 4c,d, n = 6–8, p < 0.0001). In males, the 
mean visceral WAT rose from 3.3% of body weight in WT to 5.4% in Mc3r KO, 7.7% in Mc4r KO, and 6.8% in 
DKO respectively (Fig. 4b, n = 4–8, p ≤ 0.0001). In females, it rose from 2.2% of body weight in WT to 8.9% in 
Mc3r KO, 9.4% in Mc4r KO, and 8.1% in DKO (Fig. 4d, n = 6–8, p < 0.0001). These differences in body fat were 
also reflected in adipocytes. All three mutants had an enlarged average size for adipocytes, with DKO display-
ing the greatest enlargement (Fig. 4e, n = 6, p = 0.05 for Mc3r KO, p = 0.02 for Mc4r KO, p = 0.0002 for DKO). 
Altogether, the above data showed that Mc4r KO and DKO had a higher serum lipid content, while Mc3r KO only 
showed an additive effect on top of Mc4r KO. Furthermore, all mutant rats displayed increased visceral WAT as 
well as enlarged adipocyte size.
Effect of MC3R and MC4R deficiency on liver and kidney. Next we examined whether there was any 
change in the liver of mutant rats. Results showed that Mc3r KO rats had a relatively smaller liver, whereas Mc4r 
www.nature.com/scientificreports/
3Scientific RepoRts | 6:34938 | DOI: 10.1038/srep34938
Figure 1. Effect of MC4R and MC3R deficiency on body weight, body length and Lee’s index. (a) Body 
weight and (b) Relative body weight were measured from postnatal day (PND) 45 to 85 for Mc3r KO, Mc4r KO, 
DKO and WT littermates (n = 8 except 6 for DKO, repeated measures analysis followed by Bonferroni post-
tests). Nose-anus length (c,d) and Lee’s index (e,f) of Mc3r KO, Mc4r KO, and DKO rats vs. WT littermates 
(n = 8 except 4 for DKO) at 14 weeks of age (one-way ANOVA test). Data are shown as mean ± SEM. *p < 0.05, 
**p < 0.01, ***p < 0.001 vs. WT control.
www.nature.com/scientificreports/
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KO and DKO rats had significantly larger livers as compared to WT littermates (Fig. 5a, n = 8, p = 0.0005 for Mc4r 
KO, p < 0.0001 for DKO). Mc3r KO and DKO rats showed elevated alanine aminotransferase and aspartate ami-
notransferase (Fig. 5b,c). However, when we checked up hematoxylin-eosin (HE) staining of liver sections, it was 
obvious that the Mc3r KO liver was indistinguishable from WT liver, while livers of Mc4r KO and DKO showed 
accumulation of lipid in the intracellular vesicles, with the phenotype more severe in DKO livers (Fig. 5d,e). To 
confirm the result, we subjected liver slides to oil Red-O staining. There were significantly more red stained areas 
in Mc4r KO and DKO liver sections indicating the presence of higher level of lipids, whereas no significant change 
was observed in the liver of Mc3r KO (Fig. 5f,g, n = 6, p < 0.0001).
Effects of MC3R and MC4R deficiency on the kidney were also examined. A smaller relative kidney size was 
found in Mc3r KO and DKO rats. Elevation of uric acid was only observed in DKO. Creatinine was reduced 
in Mc4r KO. Importantly, HE staining of kidneys from KO rats did not show any significant alteration (see 
Supplementary Fig. S3). Therefore, MC4R deficiency led to liver steatosis but did not cause significant change in 
kidney histology. MC3R deficiency alone was not enough to produce a significant alteration in the liver, but it did 
aggravate the pathological effect of MC4R deficiency.
Characterization of glucose metabolism. When blood glucose homeostasis was evaluated in different 
groups of rats, we found that glucose tolerance states were unchanged in all Mc3r KO rats. At 8 weeks of age only 
DKO rats showed a reduced glucose tolerance, while both Mc4r KO and DKO rats demonstrated a reduced tol-
erance by the end of 14 weeks (Fig. 6a,b). We then evaluated whether there was any change in the postprandial 
blood glucose (PBG) level. Only DKO rats showed elevated PBG levels at 7 weeks (n = 8, p = 0.0008), but both 
Mc4r KO and DKO displayed hyperglycaemia by 13 weeks of age (Fig. 6c, n = 6, p = 0.02 for Mc4r KO, p = 0.002 
for DKO). These results were partly in line with the previous report in which serum glucose was unchanged at 4–8 
week old, but started to show hyperglycemia at 10–14 weeks of age in male Mc4r KO mice8, although in our study, 
both male and female Mc4r KO or DKO rats presented the same glucose metabolism characteristics. In addition, 
a significant elevation of glycosylated hemoglobin (HbA1C) was observed in both Mc4r KO and DKO rats at 14 
weeks of age, whereas no change was manifested in Mc3r KO (Fig. 6d,e, n = 6–8, p = 0.0005 for Mc4r KO and 
p < 0.0001 for DKO). Similarly, insulin was elevated in both Mc4r KO and DKO rats at 14 weeks of age (Fig. 6f, 
n = 6–8, p = 0.01 for Mc4r KO, p = 0.04 for DKO). Leptin levels were also elevated in Mc4r KO as well as DKO 
Figure 2. Food and water intake in different mutant rat models. (a) Food intake in Mc3r KO, Mc4r KO and 
DKO vs. WT littermates. (b) Water intake in Mc3r KO, Mc4r KO and DKO vs. WT littermates. Data are shown 
as mean ± SEM (n = 6). *Difference between mutant and WT littermates. #Difference between Mc3r KO vs. 
Mc4r KO and DKO. &Difference between Mc4r KO and DKO. #,& and *p < 0.05; ##,&& and **p < 0.01; ###,&&& and 
***p < 0.001 vs. WT control (one-way ANOVA test).
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Figure 3. Serum lipid profile. (a) Typical appearance of serum from different groups of rats. (b) Total 
cholesterol (c) Triglyceride, (d) Free fatty acid, (e) Low-density lipoprotein cholesterol (LDL-c) and (f) High 
density lipoprotein cholesterol (HDL-c) of Mc3r KO, Mc4r KO, DKO rats and WT littermates at 8 weeks of age 
(n = 10–16). Data from male and female rats were merged as they showed a similar pattern and are shown as 
mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs. WT littermates (one-way ANOVA test).
www.nature.com/scientificreports/
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rats, although the latter did not reach the significant level (Fig. 6g, n = 6–8, p = 0.007 in Mc4r KO, p = 0.07 for 
DKO). At the same time, Mc3r KO did not display any significant alteration in insulin or leptin levels (Fig. 6f,g). 
Figure 4. Visceral total WAT and adipocytes. Visceral total white adipose tissue (WAT) weight (a,c) and 
percentage of body weight (b,d) of Mc3r KO, Mc4r KO, DKO and WT controls of 14-week old male and female 
rats (n = 8 except 4–6 for DKO). Data are shown as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs. WT 
control (one-way ANOVA test). (e) Representative images of adipocytes of Mc3r KO, Mc4r KO, DKO rats and 
WT littermates, together with quantitation (magnification × 100 and ×400), from at least 3 animals of each 
genotype.
www.nature.com/scientificreports/
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The above results suggested that although Mc3r KO did not show a significant change in glucose metabolism, it 
showed an additive effect on top of Mc4r KO and led to an earlier and more severe hyperglycaemia in DKO.
Discussion
In this study, we report rat models of Mc3r total KO, Mc4r total KO and Mc3r/Mc4r DKO in a homogenous back-
ground, and provide a systematic comparison of MC3R and MC4R functions in energy metabolism. Our data 
reinforce previous reports about MC4R’s role in energy metabolism. However, for the first time MC3R deficiency 
was found to display a reduced body weight, whereas at the same time exhibited additive effects on top of MC4R 
Figure 5. Alteration of liver in MC3R and MC4R deficient rats. (a) Relative liver weight (as percentage of 
body weight) of Mc3r KO, Mc4r KO, DKO and WT littermates at 14 weeks (n = 8). (b) Alanine aminotransferase 
and (c) Aspartate aminotransferase of Mc3r KO, Mc4r KO, DKO and WT littermates (n = 8). Data are shown as 
mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 vs. WT littermates (one-way ANOVA test). (d,e) Representative 
image of HE staining and (f,g) Oil Red-O staining of livers from at least 3 animals per group (magnification × 100). 
Relative areas of vacuolation or Oil Red O staining were quantified using Image-Pro® Plus version 6.0 software.
www.nature.com/scientificreports/
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deficiency in lipid and glucose metabolism. This report will be useful not only in understanding the effects of 
MC3R and MC4R deficiency in obesity and obesity-related diseases, but also provides better options of rat models 
that can be used in obesity and type 2 diabetes studies. Compared with other obesity rat models, our Mc4r KO 
and DKO manifested a relatively earlier hyperglycaemia on a normal chow diet (Table 1). Zucker rats have normal 
blood glucose28, while Mc4rK314x rats were reported have to be maintained on a moderately high-fat diet, with a 
limited commercial availability29.
The effect of MC4R deficiency on obesity and metabolism homeostasis is fairly consistent. Compared with 
Mc4rK314x rats, our Mc4r KO founders had a similar phenotype in body weight, food intake, insulin and lep-
tin level26, which was further confirmed in this study. We speculate that our Mc4r KO rats may have a greater 
Figure 6. Effect of MC3R and MC4R deficiency on glucose metabolism. OGTT of different groups of rats at 
(a) 8 weeks and (b) 14 weeks of age. (c) Postprandial blood glucose (PBG) of mice at indicated ages. (d,e) Hb1Ac 
concentration, (f) Insulin and (g) Leptin levels of Mc3r KO, Mc4r KO, DKO and WT littermates at 14 week 
of age. Only data (mean ± SEM, n = 6–8) from males are shown. Females showed a similar trend. *p < 0.05, 
***p < 0.001 vs. WT littermates (one-way ANOVA test).
www.nature.com/scientificreports/
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food intake increase if we use a chow diet with a higher fat content, as Mc4r KO mice were reported to show a 
fat-induced hyperphagia30,31. Additionally, our Mc4r KO rats have similar body size and hyperglycaemia phe-
notypic characteristics as Mc4r KO mice (Table 2). However, the function of MC3R is more complicated. Initial 
studies of the phenotypes of Mc3r KO mice indicated a very small body weight increase under chow diet, despite 
the increased fat mass16,32. In addition, there was no hyperphagia or glycaemia, indicating that Mc3r KO mice are 
more protected from metabolic syndrome compared to other obesity models with similar levels of adiposity33. 
More recent studies have demonstrated an exaggerated diet-induced obese phenotype in Mc3r KO12,34. However, 
while Mc3r KO fed on a high fat diet achieved a level of adiposity comparable to that observed in Mc4r KO mice, 
the insulin resistant phenotype remained modest and less severe35. While most of our data related to Mc3r KO 
were consistent with previous mouse data including increased adiposity, it is worth noting that there were some 
significant difference (Table 2). First, our Mc3r KO rats displayed a significant reduction in body weight and food 
intake as compared to WT littermates. Furthermore, from PND 45 to 85 (which is the usual age for rats used in 
biological research), DKO rats displayed almost the same body weight and weight gain as Mc4r KO rats. Previous 
reports stated that Mc3r/Mc4r DKO mice were significantly heavier than Mc4r single KO mice at the age of 26 
weeks, although no data demonstrated whether any difference existed before this age16,36. Although it seems dif-
ferent from results in mice, the reduction or lack of additive effect in body weight of Mc3r deficient rats is consist-
ent with the reported notion that MC3R is an inhibitory autoreceptor on proopiomelanocortin (POMC) neurons. 
This inhibitory role of MC3R was suggested when the MC3R agonist, D-trp8-γ -MSH (melanocyte stimulating 
hormone) was found to cause an increase in food intake which was absent in MC3R KO mice37. However, it is 
also possible that the reduced body size of our Mc3r KO rats is due to other reasons, such as reduced hunger sen-
sations owing to an attenuated response of AgRP/Npy neurons38. There were no MC3R null humans. Although 
MC3R mutations had been reported to associate with obesity in human17–19,39,40, whether MC3R variants play a 
causative role still needs more investigation. Therefore it is urgent that the physiological function and signalling 
of MC3R be clarified. Up till now, the signal pathway of MC3R is not well defined. Results generated from various 
models were quite different. Some groups reported that MC3R coupled to adenylyl cyclases through Gs, leading 
to stimulation of cAMP production12,41. Others demonstrated calcium as well as MAP kinase activation in ex vivo 
or in vivo models41–44.
Despite the fact that MC3R and MC4R deficiency showed an opposite effect on food consumption and body 
weight in our mutant rats, we observed additive effects of Mc3r KO to Mc4r KO in phenotypes including adipo-
cyte size, hepatic steatosis, lipid profile, OGTT and hyperglycaemia. This suggests that MC3R has a more compli-
cated role in energy regulation. It may exert different functions on feeding behavior and lipid regulation through 
different signalling pathways. In fact, MC4R was recently found to exert distinct physiological functions through 
different G proteins. The research found that in addition to the effect of MC4R on glucose metabolism and energy 
expenditure which are mediated by Gα s, a pathway for appetite regulation was identified which was mediated 
by Gα q/1145. It is known that melanocortin receptors share some common natural agonists, but with different 
affinities and different signalling pathways. This maybe one of the reasons why MC3R and MC4R have additive 
effects in energy metabolism. In addition, both MC3R and MC4R are expressed in the CNS as well as in dis-
tinct peripheral sites such as gut, muscle, pancreas13,46,47. They had been reported to exert central and peripheral 
actions in energy metabolism48. It is very likely that MC3R and MC4R regulate adiposity and lipid metabolism 
using different mechanisms, and both of them together could more accurately regulate energy balance.
Mc4r KO DKO Mc4rK314x Zucker Lepr−/−52
Obesity appears at 4–6 weeks appears at 4–6 weeks appears at 4 weeks25 appears at 4 weeks appears at 4 weeks
Hyperphagia yes yes yes yes yes
Blood glucose hyperglycaemia at 12 weeks hyperglycaemia at 8 weeks — normal blood glucose28 hyperglycaemia only observed in males
Glucose intolerance appears at 14 weeks appears at 8 weeks — delayed onset53 appears at 8 weeks
Lipid profile high lipid content higher than Mc4r KO — — —
Diabetic complication liver steatosis liver steatosis — renal54 pancreas, liver and renal lesion
Table 1.  Comparison of our Mc4r KO and DKO rats with other obesity rat models.
Mc3r KO rats Mc4r KO rats DKO rats Mc3r KO mice16 Mc4r KO mice8,50 DKO mice
Body weight reduced increased Increased, same level as Mc4r KO slight increase after 24 weeks increased
increased, more than 
Mc4r KO at 26 weeks16
Fat mass increased increased increased increased increased —
Body length reduced increased increased reduced increased —
Hyperphagia hypophagia yes yes hypophagia yes —
Glucose normal T2D T2D normal T2D —
Insulin normal increased increased mild increase at 24 weeks increased —
Leptin normal increased mild increase mild increase at 24 weeks increased —
Table 2.  Comparison of previous Mcr KO mice and our Mcr KO rats.
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Our data confirmed the notion that MC3R has a critical role in inhibition of energy storage, and its ablation 
led to the increased body fat16,32. However, despite the obvious increase in body fat, we did not observe alterations 
in lipid contents of Mc3r KO rats, indicating that MC3R by itself does not have a dominant function in lipid 
metabolism. While Mc3r KO showed a subtle phenotype, DKO exhibited worse phenotypic features than single 
KO rats, suggesting that both receptors are important and non-redundant in energy balance and that some inter-
actions probably exist between them. The phenotype of Mc3r KO might even be dependent upon the presence 
of MC4R. A number of MC3R and MC4R agonists have been developed, yet none of them has demonstrated 
satisfactory selectivity12,49. It is important to identify more selective agonists for MC3R and MC4R in order to 
elucidate their precise physiological functions in vivo. For obesity or diabetic drug development, it may be more 
attractive to look for pathway selective compounds of these receptors to regulate specific functions.
In conclusion, this study is the first systematic comparison of MC3R and MC4R single deficiency and double 
deficiency in rats with the same genetic background. It seems these two receptors possess non-redundant but 
somewhat overlapping functions in energy metabolism. Although MC3R deficiency led to a reduction of food 
consumption and body weight, it did show some additive effects on top of MC4R deficiency in both lipid and 
glucose metabolic disorders, which suggests different signalling pathways exist for MC3R. Data presented in 
this paper shed some new lights on the mechanism of MC3R and MC4R function in metabolic regulation and 
revealed potential interactions between MC3R and MC4R deficiency. The Mc4r KO and DKO rats generated in 
our lab will be beneficial for future studies to further elucidate MC3R and MC4R’s function and signalling path-
ways, and provide better rat models for novel anti-obesity or anti-diabetic drug development. In addition, the 
Mc3r KO rat might have its own value as a unique model in which high adiposity is not linked with body weight 
increase and insulin resistance.
Methods
Animals. Heritable total Mc3r or Mc4r gene knockout were generated using CRISPR-Cas9 system in our 
lab26, using Sprague Dawley (SD) rats from SLAC Laboratory Animal Co., Ltd. (Shanghai, China). The single KO 
homozygotes were breed from heterozygotes, and Mc3r/Mc4r DKO were generated by intercrossing double-het-
erozygous rats. The mutant rats appeared phenotypically normal except for changes in body weight and size. No 
obvious developmental and reproductive defects were noticed which was consistent with that reported in mouse 
models50. Animals were housed 2 per cage, maintained in a specific pathogen-free facility on 12-hour light/12-
hour dark cycles at a constant room temperature (22 ± 1 °C), with free access to water and chow diet (18% protein 
and 6% fat, Xietong Medical and Biological Engineering Co. Ltd., Jiangsu, China). Food and water were weighed 
before and after each change, and the difference was calculated as estimated intake. Minimal bedding was used for 
easy inspection of possible abnormal spillage, which was not observed. In fact spillage was very little and similar 
in all four genotypes. All animal experimental procedures and techniques were approved by the Animal Ethics 
Committee of East China Normal University (Permit number: R20151504), and methods were carried out in 
accordance with the approved guidelines.
Genotype of Mc3r and Mc4r KO rats. Tail clips were subjected to a standard DNA extraction proce-
dure. Identification of the Mc4r mutation was done by PCR, with primers 5′ -GTCCGCCACAGCCAGACTAC-3′ 
(sense) and 5′ -CGCTGCTTCTGACCCTGTTC-3′ (antisense). The Mc3r mutation was identified by PCR with 
primers 5′ -CCCAGCAGCTTGCTCAGGAC-3′ (sense) and 5′ -CTCCAGGGAGTTGGACAGGC-3′ (antisense), 
together with bpm1 (New England Biolabs Inc., USA) digestion analysis. Mutations in Mc3r and Mc4r were 
successfully transmitted to the following generations. The genotypes of all of the rats were verified as correct.
Quantitative real-time PCR analysis. Rats were sacrificed and total RNA was isolated from brain, liver and 
WAT with TRIzol (Invitrogen). Possible DNA contamination was eliminated using DNase I (Amplification Grade, 
Invitrogen). The purified RNA was then reverse-transcribed to cDNA using the Prime Script RT kit (Takara). 
Real-time PCR was performed in quadruplicate with a SYBR Green PCR Master Mix (Takara) according to the 
manufacturer’s instruction and ran on the MX3005p system (Stratagene, USA). Data were calculated through 
MXProv4.1. (Stratagene, USA). Primers (synthesized by Shanghai Biosune, China) were as follows: Mc3r, (forward) 
5′ -TGCTGCCCGTCCTCCTCTTA-3′ and (reverse) 5′ -CCAGGATCACCAGGATGTTTT-3′ ; Mc4r, (forward) 
5′ -GGACCACTTCAAGGAGGATT-3′ and (reverse) 5′ -CACCCAGAGTCACAAACACC-3′ ; the reference gene 
GAPDH, (forward) 5′ -TCTCTGCTCCTCCCTGTTCT-3′ and (reverse) 5′ -TACGGCCAAATCCGTTCACA-3′ .
Bodyweight, size and Lee’s index calculation. Weight gain was monitored throughout the study. For 
animal size, rats were anesthetized with isoflurane (Hebei Yipin Pharmaceutical Co. Ltd, Hebei, China) and body 
length (from anus to nose) was measured. Because there is possible body length change in the mutant rats, we 
used Lee’s index as an additional measurement for the degree of obesity. Lee’s index was calculated as bodyweight 
(gram)1/3/body length (cm) × 100051.
Biochemical analysis. Blood was collected from the retro-orbital plexus and serum was obtained by cen-
trifugation at 3000 rpm for 15 minutes at 4 oC, which was kept frozen at − 80 oC until analysis. Serum triglyceride, 
total cholesterol, aspartate aminotransferase, alanine aminotransferase, uric acid, creatinine, LDL-c and HDL-c 
were analyzed using the AU680 Automatic Biochemistry Analyzer (Beckman Coulter, USA). Serum insulin, lep-
tin and free fatty acid levels were measured using ELISA kits (R&D systems, USA). For HbA1c measurement, 
plasma samples were tested in a rat HbA1c kit (Shensuo Youfu Medical Diagnosis Products Co. Ltd, Shanghai, 
China) according to the manufacturer’s instruction. PBG levels of overnight fasted rats were measured 2 h after an 
oral glucose challenge at 2 g/kg, using a portable glucose meter (ACCU-CHEK Performa Nano, Roche).
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Oral Glucose Tolerance Test (OGTT). Animals were fasted overnight and blood glucose was measured 
from tail bleeds before and 15, 30, 45, 60, 90, and 120 minutes after intragastric administration of 50% glucose 
(2.5 g/kg), using the Roche glucose meter.
Hematoxylin-Eosin (HE) staining. Rats were sacrificed by CO2 inhalation. Visceral adipose tissue, liver and 
kidney samples were collected and fixed overnight in ice-cold 4% paraformaldehyde solution, then embedded in par-
affin. Serial 5 μ m sections were cut and stained with hematoxylin-eosin for histological analysis. Images were captured 
on a Leica DM4000 B LED microscope with a Leica DFC310FX Camera and software kit. Quantification of HE stain-
ing was done by Image-Pro® Plus version 6.0 software. A minimum of 5 independent fields per sample was evaluated.
Oil Red-O staining. Liver samples were fixed overnight in 4% paraformaldehyde, followed by immersion in 15% 
and then 30% sucrose. Serial 5 μ m sections were cut and stained with the Oil Red-O staining kit (Jiancheng Scientific 
Inc., Nanjing, China) for 3~5 minutes in accordance with the manufacturer’s instruction, and finally counterstained 
with hematoxylin. Relative areas of lipid accumulation (expressed as percentage Oil Red-O staining) were quantified 
using Image-Pro® Plus version 6.0 software. A minimum of 5 independent fields per sample was evaluated.
Statistical analyses. Data are expressed as mean ± SEM. One way ANOVA followed by Turkey’s multi-
ple comparisons test was applied to analyse differences among groups, except for body weight (Fig. 1a,b and 
Supplementary Fig. S2), where the comparisons were analysed using repeated measures analysis followed by 
Bonferroni post-tests. p < 0.05 was considered to be statistically significant.
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